EVALUATION OF THE THERAPEUTIC EFFECT OF THE COMBINED USE OF CRYOPRESERVED PLACENTA EXTRACT AND DICLOFENAC SODIUM IN EXPERIMENTAL RHEUMATOID ARTHRITIS BY HEMATOLOGICAL PARAMETERS
Article PDF (Українська)

Keywords

cryopreserved placenta extract, diclofenac sodium, nonsteroidal anti-inflammatory drugs, chronic inflammatory anemia

Abstract views: 38
PDF Downloads: 24

How to Cite

Hladkykh , F. V. (2021). EVALUATION OF THE THERAPEUTIC EFFECT OF THE COMBINED USE OF CRYOPRESERVED PLACENTA EXTRACT AND DICLOFENAC SODIUM IN EXPERIMENTAL RHEUMATOID ARTHRITIS BY HEMATOLOGICAL PARAMETERS. Medical Science of Ukraine (MSU), 17(3), 15-21. https://doi.org/10.32345/2664-4738.3.2021.02

Abstract

Relevance. Cryopreserved placenta extract (CPE) increase the resistance of the mucous membrane of the gastrointestinal tract to the damaging effects of nonsteroidal anti-inflammatory drugs. Preventive administration of CPE can reduce the ulcerogenic effect of meloxicam, ibuprofen, diclofenac sodium (DS) and others. There is evidence of CPE's own anti-inflammatory activity, which can be successfully combined with the pharmacological properties of nonsteroidal anti-inflammatory drugs, while improving their safety profile.

Objective: to characterize the therapeutic activity of the combined use of CPE and DS according to hematological parameters in the model of experimental rheumatoid arthritis (RA).

Materials and methods. Studies were performed on 28 nonlinear laboratory rats. The rats were divided into 4 groups: I (n = 7) – intact rats; II (n = 7) – rats with experimental RA; ІІІ (n = 7) – rats with experimental RA, treated with DN; IV (n = 7) – rats with experimental RA, treated with DN and CPE. Adjuvant arthritis was modeled by subplantar administration of complete Freund's adjuvant. Treatment was performed from 14 to 28 days. CPE was administered on days 14, 17, 20, 23 and 26, and DS – daily. Blood tests were performed on day 28 of the experiment.

Results. The combined use of CPE and DS is accompanied by a more pronounced leveling of inflammatory signs by hematological parameters – erythrocyte clotting rate decreased by 72.2% (p<0.001), and the number of leukocytes decreased by 54.81% (p<0.001) relative to rats with adjuvant arthritis without treatment. There was a leveling of signs of anemia of chronic inflammation – the level of hemoglobin and erythrocytes increased (p<0,001) by 17.6% and 36.8%, respectively, relative to rats with adjuvant arthritis without treatment.

Conclusions. The combined use of CPE and DS is superior in therapeutic activity to monotherapy with this nonsteroidal anti-inflammatory drug of experimental rheumatoid arthritis.

https://doi.org/10.32345/2664-4738.3.2021.02
Article PDF (Українська)

References

Anikin GS, Stozhkova IV, Kukes VG. NSAIDs: safety from the point of evidence-based medicine. Consilium Medicum. 2017; 19: 28-32. [in Ukrainian] DOI: 10.26442/2075-1753_19.7.2.28-32

View at:

Cyberleninka: https://cyberleninka.ru/article/n/nesteroidnye-protivovospalitelnye-preparaty-bezopasnost-s-pozitsii-dokazatelnoy-meditsiny

URL: https://omnidoctor.ru/upload/iblock/8d2/8d2f96c2485deaf5dc49676a474b6b90.pdf

Wasserman A. Rheumatoid Arthritis: Common Questions About Diagnosis and Management. American Family Physician. 2018;97(7):455-62.

View at:

Publisher Site: https://familydoctor.org/condition/rheumatoid-arthritis/

Semanticscholar: https://www.semanticscholar.org/paper/Rheumatoid-Arthritis%3A-Common-Questions-About-and-Wasserman/ad88a50ea1281388fc02bad089055e2f142657e3

Woude D, Helm-van Mil HM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 2018; 32 (2): 174-87. DOI: 10.1016/j.berh.2018.10.005.

View at:

Scopus: https://www.sciencedirect.com/science/article/abs/pii/S1521694218300688?via%3Dihub

PubMed: https://pubmed.ncbi.nlm.nih.gov/30527425/

Otón T, Carmona L. The epidemiology of established rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 2019; 33 (5): 101477. DOI: 10.1016/j.berh.2019.101477.

View at:

Scopus: https://www.sciencedirect.com/science/article/abs/pii/S1521694219301731?via%3Dihub

PubMed: https://pubmed.ncbi.nlm.nih.gov/31987685/

Ghosh N, Kolade OO, Shontz E, Rosenthal Y, Zuckerman JD, Bosco JA 3rd, Virk MS. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Their Effect on Musculoskeletal Soft-Tissue Healing: A Scoping Review. The Journal of Bone and Joint Surgery. 2019; 7 (12): e4. DOI: 10.2106/JBJS.RVW.19.00055.

View at:

Publisher Site: https://journals.lww.com/jbjsreviews/Abstract/2019/12000/Nonsteroidal_Anti_Inflammatory_Drugs__NSAIDs__and.2.aspx https://journals.lww.com/jbjsreviews/Abstract/2019/12000/Nonsteroidal_Anti_Inflammatory_Drugs__NSAIDs__and.2.aspx

PubMed: https://pubmed.ncbi.nlm.nih.gov/31851037/

Cunningham K, Candelario DM, Angelo LB. Nonsteroidal Anti-Inflammatory Drugs: Updates on Dosage Formulations and Adverse Effects. Orthopaedic Nursing. 2020; 39 (6):408-13. DOI: 10.1097/NOR.0000000000000713.

View at:

Publisher Site: https://journals.lww.com/orthopaedicnursing/Abstract/2020/11000/Nonsteroidal_Anti_Inflammatory_Drugs__Updates_on.12.aspx

PubMed: https://pubmed.ncbi.nlm.nih.gov/33234913/

Satybaldyev AM, Karateev AE. What is safer for the gastrointestinal-tract: Coxibs or meloxicam? Modern Rheumatology. 2017; 11 (1): 72-8. [in Russian]. DOI: 10.14412/1996-7012-2017-1-72-78.

View at:

Publisher Site: https://mrj.ima-press.net/mrj/article/view/742

Cyberleninka: https://cyberleninka.ru/article/n/chto-bezopasnee-dlya-zheludochno-kishechnogo-trakta-koksiby-ili-meloksikam

Bacchi S, Palumbo P, Sponta A, Coppolino MF. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 2012; 11 (1): 52-64. DOI: 10.2174/187152312803476255.

View at:

Publisher Site: https://www.eurekaselect.com/102932/article

PubMed: https://pubmed.ncbi.nlm.nih.gov/22934743/

Hladkykh FV, Chyzh MO. Modulation of meloxicam-induced changes in gastrointestinal and motor activity of the stomach by applying placenta cryoextract. Proceedings of the Shevchenko Scientific Society. Medical Sciences. 2021; 64 (1): 84-94. DOI: 10.25040/ntsh2021.01.08.

View at:

Publisher Site: https://mspsss.org.ua/index.php/journal/article/view/400

Stefanov OV. Preclinical studies of drugs: guidelines. Kyiv: Avicenna; 2001. 527 p. [in Ukrainian].

View at:

Publisher Site: https://www.twirpx.com/file/537410/

Rybolovlev UR, Rybolovlev RS. Dosage of substances for mammals by constants of biological activity. Reports of the USSR Academy of Sciences. 1979; 247 (6): 1513-6. [in Russian].

Goltsev AN, ed. Placenta: cryopreservation, clinical use. Kharkiv, 2013. 268 p. [in Russian].

View at:

URL: http://elib.umsa.edu.ua/jspui/bitstream/umsa/3692/3/kniga.pdf

Karateev AE, Nasonov EL, Ivashkin VT, Martynov AI, Yakhno NN, Arutyunov GP, Alekseeva LI, Abuzarova GR, Evseev MA, Kukushkin ML, Kopenkin SS, Lila AM, Lapina TL, Novikova DS, Popkova TV, Rebrov AP, Skorobogatykh KV, Chichasova NV. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guideline. Rheumatology Science and Practice. 2018; 56: 1-29. [in Russian]. DOI: 10.14412/1995-4484-2018-1-29.

View at:

Publisher Site: https://rsp.mediar-press.net/rsp/article/view/2536

Chen Y, Xu W, Yang H, Shao M, Xu S, Deng J, Gao X, Liu H, Shuai Z, Xu S, Pan F. Serum Levels of Hepcidin in Rheumatoid Arthritis and Its Correlation with Disease Activity and Anemia: A Meta-analysis. Immunological Investigations. 2021; 50 (2-3): 243-58. DOI: 10.1080/08820139.2020.1742731.

View at:

Publisher Site: https://www.tandfonline.com/doi/abs/10.1080/08820139.2020.1742731?journalCode=iimm20

PubMed: https://pubmed.ncbi.nlm.nih.gov/32216485/

Sato H, Takai C, Kazama JJ, Wakamatsu A, Hasegawa E, Kobayashi D, Kondo N, Nakatsue T, Abe A, Ito S, Ishikawa H, Kuroda T, Suzuki Y, Narita I. Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis. Scientific Reports. 2020; 10 (1): 9882. DOI: 10.1038/s41598-020-66945-3.

View at:

Publisher Site: https://www.nature.com/articles/s41598-020-66945-3

PubMed: https://pubmed.ncbi.nlm.nih.gov/32555299/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303107/

Sahebari M, Rezaieyazdi Z, Hashemy SI, Khorasani S, Shahgordi S, Alizadeh MK, Ghaeni A, Khodashahi M. Serum hepcidin level and rheumatoid arthritis disease activity. European Journal of Rheumatology. 2018; 6 (2): 76-80. DOI: 10.5152/eurjrheum.2018.18114.

View at:

Publisher Site: https://eurjrheumatol.org//en/serum-hepcidin-level-and-rheumatoid-arthritis-disease-activity-133197

PubMed: https://pubmed.ncbi.nlm.nih.gov/31365340/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467328/

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.